Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms
Andrea-Clemencia Pineda-Peña, Kohei Hasegawa, Vincent Pavot, Catherine Berry, Behazine Combadière, Guadalupe Cortes-Garcia, Adrian B. McDermott, Saranya Sridhar · 2025
Read Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms by Andrea-Clemencia Pineda-Peña, Kohei Hasegawa, Vincent Pavot, Catherine Berry, Behazine Combadière, Guadalupe Cortes-Garcia, Adrian B. McDermott, Saranya Sridhar (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12717083.txt.
Description
Andrea-Clemencia Pineda-Peña and co-authors review long-lasting vaccine protection in this 2025 paper. A vaccine's worth rests on how long its immunity holds. Two modern platforms, mRNA shots and adjuvanted protein shots, raise fresh questions about durability.
The review first lays out what makes an immune response last. Design of the vaccine, traits of the host, and traits of the germ all play a part. It then sums the evidence on how long responses from each platform endure. Hurdles for durable mRNA vaccines get special attention. The authors close with points to guide future vaccine design for longer protection.
Catalog record
| CREATOR | Andrea-Clemencia Pineda-Peña, Kohei Hasegawa, Vincent Pavot, Catherine Berry, Behazine Combadière, Guadalupe Cortes-Garcia, Adrian B. McDermott, Saranya Sridhar |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |